Compensating clinical trial participants from limited resource settings in internationally sponsored clinical trials: A proposal

被引:0
|
作者
Ndebele, Paul [1 ]
Mfutso-Bengo, Joseph
Mduluza, Takafira [2 ]
机构
[1] Coll Med, Ctr Bioeth Eastern & So Africa, Dept Community Hlth, CEBESA, Blantyre 3, Malawi
[2] Univ Zimbabwe, Dept Student Affairs, Harare, Zimbabwe
关键词
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Trial participants from limited resource settings often are given very little or nothing in terms of compensation for time, inconvenience and risks as compared to their counterparts from developed countries. The reason that is often sited by researchers, ethics committees, and sponsors is the avoidance of undue inducements. We discuss the inherent conflict that may arise in trying to avoid undue inducement and in trying to minimize injustice in international research. We argue that research participants from both industrialized nations and those from limited resource settings should be compensated equally since they suffer the same burdens and equally contribute towards the study by contributing the same product - data. We make recommendations that acknowledge and address the existing injustice in the compensation of trial participants in international research.
引用
收藏
页码:42 / 45
页数:4
相关论文
共 50 条
  • [1] Challenges for conducting clinical trials for AIDS malignancies in resource-limited settings
    Mitsuyasu, Ronald
    CURRENT OPINION IN ONCOLOGY, 2011, 23 (05) : 461 - 462
  • [2] Diversity of US participants in AstraZeneca-sponsored clinical trials
    Cabrera, Claudia
    Fernandez-Llaneza, Daniel
    Ghazoui, Zara
    D'Abrantes, Sofia
    Esparza-Franco, M. Alejandro
    Sopp, Charles
    Maj, Beata
    Chiou, Victoria L.
    Valastro, Barbara
    Pangalos, Menelas N.
    Galbraith, Susan
    Ghiorghiu, Serban
    Massacesi, Cristian
    CONTEMPORARY CLINICAL TRIALS, 2024, 140
  • [3] Clinical oncology in resource-limited settings
    Buonaguro, Franco M.
    Gueye, Serigne N.
    Wabinga, Henry R.
    Ngoma, Twalib A.
    Vermorken, Jan B.
    Mbulaiteye, Sam M.
    INFECTIOUS AGENTS AND CANCER, 2013, 8
  • [4] Mycetoma: a clinical dilemma in resource limited settings
    Emmanuel, Pembi
    Dumre, Shyam Prakash
    John, Stephen
    Karbwang, Juntra
    Hirayama, Kenji
    ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS, 2018, 17
  • [5] Mycetoma: a clinical dilemma in resource limited settings
    Pembi Emmanuel
    Shyam Prakash Dumre
    Stephen John
    Juntra Karbwang
    Kenji Hirayama
    Annals of Clinical Microbiology and Antimicrobials, 17
  • [6] Clinical oncology in resource-limited settings
    Franco M Buonaguro
    Serigne N Gueye
    Henry R Wabinga
    Twalib A Ngoma
    Jan B Vermorken
    Sam M Mbulaiteye
    Infectious Agents and Cancer, 8
  • [7] Clinical trials in low-resource settings: the perspectives of caregivers of paediatric participants from Uganda, Tanzania and Kenya
    van den Berg, Machteld
    Ogutu, Bernhards
    Sewankambo, Nelson K.
    Merten, Sonja
    Biller-Andorno, Nikola
    Tanner, Marcel
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2019, 24 (08) : 1023 - 1030
  • [8] Regulatory Challenges Associated With Conducting Multicountry Clinical Trials in Resource-Limited Settings
    Ndebele, Paul
    Blanchard-Horan, Christina
    Shahkolahi, Akbar
    Sanne, Ian
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2014, 65 : S29 - S31
  • [9] Using digital technology to support and enhance clinical trials in resource-limited settings
    Lang, T.
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2012, 17 : 49 - 49
  • [10] Clinical trials in India sponsored by the pharmaceutical industry: A proposal for reforms
    Pai, M
    Colford, JM
    NATIONAL MEDICAL JOURNAL OF INDIA, 2002, 15 (02): : 93 - 96